COCIR welcomes the adoption of the extended transitional provisions for Regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). The temporary risk-based extension of transitional periods has proved necessary to counteract bottlenecks in the supply of Medical Devices and in MDR certification towards 2024, ensure access to the market to all already established and safe devices and, ultimately, guarantee continuity of patient care across Europe.

Download Statement form Related Files